Bioservo signs a distributor agreement with Hidrex for the sales of Carbonhand[®] in Germany

Bioservo strengthens the sales channel in Germany, the largest market in Europe, and complements the network with another distributor. Through Hidrex GmbH's sales network, Carbonhand^® can help people with impaired hand function all over Germany.

Hidrex GmbH was founded back in 1974 and has worked with rehabilitative aids since 1976. Today they have over 40 employees and a turnover of around seven million Euros through the sale of aids and disability equipment to around 200 hospitals, clinics, and rehab centers through around forty local dealers around Germany. They have solid experience with the German reimbursement system and have a department that focuses exclusively on rehabilitative aids and assistive robots.

"We are very happy to be able to link Hidrex to our distributor network and thus gain a wider geographical coverage on the German market. They will also be a good complement to our existing distributor in Germany in that they largely addresses other target groups.” says Petter Bäckgren, CEO of Bioservo, and continues: "Hidrex's long experience and competence within the German reimbursement system will be an important success factor in being able to get our recently launched Carbonhand to all those living with impaired hand function in Germany today."

For more information 
Petter Bäckgren, CEO, Bioservo Technologies AB
+468 21 17 10
[email protected]

Niklas Lagström, Global Brand Manager – Life Science, Bioservo Technologies AB
+468 21 17 10
[email protected]

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company’s Certified Adviser on Nasdaq First North. 
For more information, please visit www.bioservo.com